Results 61 - 70 of 92 : Previous 2 3 4 5 6 7 8 9 10 Next
The release of data on an oral version of its lead heart drug is delayed.
Johnson & Johnson Reorganizes -- Who Wins?
J&J's internal shuffle will help other companies.
Barr's acquisition increases sales, but it can't raise the bottom line.
The drugmaker releases its third-quarter financial results.
Foolish Forecast: Tenacious Teva
Views you can use to get clues on tomorrow's news.
New FDA Regulations for Drugmakers
They have few side effects for generic-drug makers.
"Dear Doctor" Letter Spells Trouble for Cephalon
The potential for harm reduces the uses of painkiller Fentora.
The future is tantalizing. But is it within reach?
Teva Spending Plenty of Time in Court
Three patent disputes in one week keep the lawyers busy.
Foolish Fantasy Football: 3 Drug Companies
Offense, defense, special teams -- the industry has it all.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK